shutterstock_1696929460.jpg

DXC Covid Vaccination

COMORBID A3 GROUP PRIORITIZATION

ABOUT US

AIDE Mobile App

A Platform That Connects You to Local Home Care Experts Who are Ready to Serve

AIDE is the most reliable and trustworthy Home Health Care Platform in the greater Metro Manila area — providing excellent home care solutions to patients who are dealing with injury or illness. Our medical partners are committed to meeting all of your health needs, and go above and beyond to ensure you get the best care available.

2
3
4
DEPARTMENT OF HEALTH

National Vaccine Deployment Plan for COVID-19

On March 1, 2021, the National Government has initiated the rollout of the COVID-19 Vaccine Deployment Program with the use of the SARS-COV-2 Vaccines in efforts to:

 

1) reduce morbidity and mortality while maintaining the most critical essential services;

 

2) protect those who bear significant additional risks and burdens of COVID-19 to safeguard the welfare of others;

 

3) substantially slow down rate of transmission and minimize disruption of social, economic, and security functions; and

 

4) responsibly resume social and economic day-to-day operations and activities.

1200px-Department_of_Health_(DOH)_PHL.sv
COVID-19 VACCINES

Protect Yourselves

Learn more about the various types of COVID-19 vaccines and why they can help us in our battle against COVID. Be informed and stay up to date with the latest scientific breakthroughs.

Prioritization Groups

PHASE 1
1
circle.png
A1
Frontliners

Frontline workers in health facilities both national and local, private and public, health professionals and non-professionals like students in health and allied professions courses with clinical responsibilities, nursing aides, janitors, barangay health workers, etc. 

circle.png
A2
Senior citizens

Senior citizens aged 60 years old and above 

circle.png
A3
Adults with comorbidities

Priority shall be given to adult whose comorbidities are among the top causes of COVID-19 and national morbidity and mortality for prioritization to include: chronic respiratory disease, hypertension, cardiovascular disease, chronic kidney disease, cerebrovascular disease, malignancy, diabetes, obesity, chronic liver disease, neurologic disease, and immunodeficiency state.

circle.png
A4
Essential Workers

Frontline personnel in essential sectors both in public and private sectors, including uniformed personnel, and those in working sectors identified by; the IATF that are directly client facing and cannot dutifully meet minimum public health standards 

circle.png
A5
Indigent Population

Poor population based on the National Household Targeting System for Poverty Reduction (NHTS-PR) not otherwise included in the preceding categories

DEPARTMENT OF HEALTH

A3 Prioritization Guidelines

Eligibility

 

a. Any adult between 18-59 years old with any controlled comorbidity can be part of Priority Group A3.

 

b. Priority shall be given to adult whose comorbidities are among the top causes of COVID-19 and national morbidity and mortality for prioritization to include

 

  • chronic respiratory disease,

  • hypertension,

  • cardiovascular disease,

  • chronic kidney disease,

  • cerebrovascular disease,

  • malignancy,

  • diabetes,

  • obesity,

  • chronic liver disease,

  • neurologic disease, and

  • immunodeficiency state.

 

c. Any of the following may be provided as proofs of comorbidity issued within the past 18 months:

 

  1. Medical certificate from an attending physician;

  2. Prescription for medicines;

  3. Hospital records such as the discharge summary and medical abstract;

  4. Surgical records and pathology reports 2. In case of limited vaccine supply, further sub-prioritization of Priority

 

Group A3 shall be done based on geographic burden of COVID-19 disease and LGU vaccination readiness.

 

Additional precautionary measures for implementation of vaccine deployment with Priority Group A3 shall be as follows: a. Administration of vaccines shall take into consideration specific comorbidities indicated as contraindications and precautions in vaccine productlist or in the EUA issued by the Philippine Food and Drug Administration. b. Vaccines shall not be administered to those with uncontrolled or poorly controlled comorbidities, and those in active disease

Registration

Dear DXC Technology Employees,

 

DXC Technology (the "Company"), in line with its COVID-19 Vaccine Inoculation Program, has engaged the services of APPPPS Partners, Inc. ("AIDE") to collect the necessary personal and sensitive personal information from all employees through this webpage, which information shall be shared to AIDE's partner-doctors who will be assessing all information in order to generate a priority list for vaccination based on each employee's medical condition. 

 

By clicking "Yes," you freely and voluntarily give your consent to APPPPS Partners, Inc. (AIDE) to collect, process, share and transfer your personal and sensitive personal information for the purposes above mentioned. By virtue of the protection accorded to you by Republic Act No. 10173, or the Data Privacy Act of 2012, its Implementing Rules and Regulations, and all other relevant issuances of the National Privacy Commission, all personal and sensitive personal information collected from you in this webpage shall not be disclosed to any other person or entity outside of AIDE and its partner-doctors, nor shall any information disclosed be used for any other purposes not specifically provided herein.

 

Thank you for your cooperation.

closed.png
SIDE EFFETCS

Is it safe?

Learn more about the various types of COVID-19 vaccines and why they can help us in our battle against COVID. Be informed and stay up to date with the latest scientific breakthroughs.

 
DOWNLOAD AIDE TODAY AND EXPERIENCE THE NEW REVOLUTION IN HEALTHCARE